Market Place
Sourcing Support
All News #Library
Others
Gilead backs out of option to buy immunotherapy-focused Tizona
06 Feb 2024 //
FIERCE BIOTECH
Gilead passes on fully acquiring Pionyr, as eyes now turn to Tizona
23 Mar 2023 //
ENDPTS
Tizona Begins Phase 1b Expansion Study of TTX-080 in Advanced r/r Malignancies
14 Oct 2021 //
BUSINESSWIRE
Biotech funder Lightstone raises another $375M for life sciences investing
14 Sep 2021 //
BIOPHARMADIVE
Tizona Appoints Christine O’Brien as Chief Executive Officer
15 Sep 2020 //
GLOBENEWSWIRE
Gilead Sciences Secures Exclusive Option to Acquire Tizona for $300 Million
23 Jul 2020 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.